Insider Trading November 11, 2026 03:15 AM

Zions Bancorporation's Chief Risk Officer Offloads $181,192 in Stock

Christopher Kyriakakis sells 2,702.555 shares at $67.045, retaining 36,700.065 shares; move comes as ZION trades at a P/E of 8.16 and after Q3 earnings beat.

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
ZION

Christopher Kyriakakis, Executive Vice President and Chief Risk Officer at Zions Bancorporation, National Association (NASDAQ:ZION), disposed of 2,702.555 shares of common stock on November 9, 2026, at $67.045 per share, for a total value of $181,192. Following the sale, Kyriakakis directly holds 36,700.065 shares. The transaction was disclosed in a filing signed by R. Ryan Richards as attorney-in-fact on November 10, 2026. The sale occurs as ZION trades at a P/E ratio of 8.16, with analysis suggesting the stock is undervalued relative to its Fair Value. Zions has raised its dividend for 14 consecutive years, maintaining a current yield of 2.9%. In recent news, Zions reported third-quarter 2026 earnings of $1.78 per share, surpassing the $1.66 estimate, though revenue of $881 million fell slightly short of the $889.98 million forecast. Net earnings available to common shareholders rose 20% year-over-year to $262 million, driven by higher net interest income and fee income. Stephens raised its price target to $78 from $75, DA Davidson increased its target to $80 from $79, and Jefferies maintained a Buy rating while adjusting its target to $75 from $80. Management expressed optimism, lifting its near-term net interest income outlook and highlighting growth in capital markets, wealth management, and a new multifamily platform.

Zions Bancorporation's Chief Risk Officer Offloads $181,192 in Stock
ZION
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Chief Risk Officer Christopher Kyriakakis sold 2,702.555 shares at $67.045, leaving him with 36,700.065 shares.
  • The sale occurs as ZION trades at a P/E of 8.16, with analysis indicating the stock is undervalued relative to Fair Value, and the bank has raised its dividend for 14 consecutive years, yielding 2.9%.
  • Zions reported Q3 2026 EPS of $1.78, beating the $1.66 estimate, while revenue of $881 million slightly missed the $889.98 million forecast; net earnings available to common shareholders rose 20% to $262 million.

Christopher Kyriakakis, Executive Vice President and Chief Risk Officer at Zions Bancorporation, National Association (NASDAQ:ZION), sold company common stock valued at $181,192 on November 9, 2026, according to a regulatory filing.

The transaction involved the disposition of 2,702.555 shares of common stock at a price of $67.045 per share. Following this sale, Mr. Kyriakakis directly holds 36,700.065 shares of Zions Bancorporation common stock. The filing was signed by R. Ryan Richards as attorney-in-fact on November 10, 2026.

The sale comes as ZION trades at a P/E ratio of 8.16, with analysis suggesting the stock is undervalued relative to its Fair Value. According to available research, the bank has raised its dividend for 14 consecutive years, maintaining a current yield of 2.9%.

In other recent news, Zions Bancorporation reported third-quarter 2026 earnings of $1.78 per share, surpassing Wall Street’s estimate of $1.66. However, the company’s revenue of $881 million fell slightly short of the $889.98 million forecast. Net earnings available to common shareholders rose by 20% from the previous year to $262 million, driven by higher net interest income and fee income.

Analyst reactions followed the earnings release. Stephens raised its price target on Zions Bancorp to $78 from $75, citing the bank’s capital strength and a strong earnings performance. DA Davidson also increased its price target to $80 from $79, noting that Zions’ core earnings per share of $1.73 exceeded their forecast by $0.10. Despite a core pre-provision net revenue miss, Jefferies maintained a Buy rating while adjusting its price target to $75 from $80.

The bank’s management expressed optimism, lifting its near-term net interest income outlook and highlighting growth in capital markets, wealth management, and a new multifamily platform.


Key points:

  • Chief Risk Officer Christopher Kyriakakis sold 2,702.555 shares at $67.045, leaving him with 36,700.065 shares.
  • The sale occurs as ZION trades at a P/E of 8.16, with analysis indicating the stock is undervalued relative to Fair Value, and the bank has raised its dividend for 14 consecutive years, yielding 2.9%.
  • Zions reported Q3 2026 EPS of $1.78, beating the $1.66 estimate, while revenue of $881 million slightly missed the $889.98 million forecast; net earnings available to common shareholders rose 20% to $262 million.

Risks and uncertainties:

  • Revenue fell short of forecasts, which could signal pressure on top-line growth.
  • Jefferies adjusted its price target downward to $75 from $80 despite maintaining a Buy rating, and noted a core pre-provision net revenue miss.
  • Insider sales may be perceived negatively by some investors, though the filing does not specify a reason for the transaction.

Risks

  • Revenue fell short of forecasts, which could signal pressure on top-line growth.
  • Jefferies adjusted its price target downward to $75 from $80 despite maintaining a Buy rating, and noted a core pre-provision net revenue miss.
  • Insider sales may be perceived negatively by some investors, though the filing does not specify a reason for the transaction.

More from Insider Trading

Six Flags Executive Chair Haddrill Purchases $90,720 in Company Shares Nov 11, 2026 SelectQuote COO William Grant Discloses $40,198 Share Purchase Nov 11, 2026 SelectQuote Director Donald Hawks III Boosts Stake with $114,218 Stock Purchase Nov 11, 2026 SelectQuote Insider Buying: President Grant Adds 79,801 Shares as Stock Trades Near $0.46 Nov 11, 2026 SelectQuote CEO Danker Boosts Stake with $50,736 Share Purchase Nov 11, 2026